Skip to content

Comparing Analgesic Effects of Morphine-Chlorpheniramine and Morphine alone in Patients with Acute Renal Colic

Comparing Analgesic Effects of Morphine-Chlorpheniramine and Morphine alone in Patients with Acute Renal Colic

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015060722582N1
Enrollment
102
Registered
2015-08-11
Start date
2014-09-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal colic. Unspecified renal colic

Interventions

Intervention 1: Intervention group:5 mg Morphine Sulfate along with 10 mg Chlorpheniramin ,over one hour, on minutes 00,15,30,45,60 by intravenous administration. Intervention 2: Control group:5 mg Mo
Treatment - Drugs
Intervention group:5 mg Morphine Sulfate along with 10 mg Chlorpheniramin ,over one hour, on minutes 00,15,30,45,60 by intravenous administration
Control group:5 mg Morphine Sulfate along with 10 mg Distilled water ,over one hour, on minutes 00,15,30,45,60 by intravenous administration

Sponsors

Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age range from 18 to 55 years old, clinical diagnosis of acute colic pain, pain intensity of 7-10 based on VAS, and patients’ consent for participation in the study. Exclusion criteria: Angle-closure Glaucoma, Symptomatic benign prostatic hypertrophy (BPH) - peptic ulcer disease - a bladder neck obstruction - pyloric or duodenal obstruction - Chronic obstructive pulmonary disease (COPD) - Asthma - sleep apnea - urinary retention - Hyperthyroidism - high intraocular pressure and blood pressure - cardiovascular diseases. Also, pregnancy or suspected pregnancy, contraindications for receiving morphine and citalopram according to the drugs’ catalog, a history of dependency on opioid or SSRIs, receiving an analgesic drug within last 6-hours, peritonitis or signs of peritoneal irritation, inability to communicate for any reason, patient’s withdrawal from participation in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: at base line (00), 15, 30, 45, 60 minutes of treatment. Method of measurement: observation, Using a 10-cm visual analog scale, the pain intensity will be measured. ( 10= intolerable pain, 1= no pain).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Behrad Ziapour

Ahvaz Jundishapur University of Medical Sciences

behradzpr@gmail.com+98 61 3336 7562

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026